HALOZYME THERAPEUTICS, INC.
HALOAPI behind this page
HALO Q1 2026 request
Playground key active
/api/financials?ticker=HALO&year=2026&quarter=1
Pick an endpoint and run the request.
Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 376,708 | 264,861 | +42.2% |
Show Product Lines breakouts |
|||
| Bulk rHuPH20 sales | 73,497 | 27,025 | +172.0% |
| Device licensing and development revenue | 5,603 | 3,408 | +64.4% |
| Device partnered product sales | 15,054 | 14,675 | +2.6% |
| Product | 130,424 | 78,041 | +67.1% |
| Proprietary product sales | 41,873 | 36,341 | +15.2% |
| Revenues under collaborative agreements | 5,603 | 18,628 | -69.9% |
| Royalty | 240,681 | 168,192 | +43.1% |
| Cost of Revenue | 79,238 | 48,403 | +63.7% |
| Amortization Of Intangible Assets | 29,512 | 17,762 | +66.2% |
| Research & Development | 25,560 | 14,799 | +72.7% |
| Selling, General & Administrative | 57,881 | 42,362 | +36.6% |
| Total Costs & Expenses | 192,191 | 123,326 | +55.8% |
| Operating Income | 184,517 | 141,535 | +30.4% |
| Other Non-Operating Income (Expense) | 1,318 | 6,818 | -80.7% |
| Interest Expense | -5,508 | -4,525 | -21.7% |
| Income Before Taxes | 180,327 | 143,828 | +25.4% |
| Income Tax Expense (Benefit) | 30,278 | 25,733 | +17.7% |
| Net Income | 150,049 | 118,095 | +27.1% |
Show Equity Components breakouts |
|||
| Retained Earnings | 150,049 | 118,095 | +27.1% |
| EPS (Basic) | 1.27 | 0.96 | +32.3% |
| EPS (Diluted) | 1.22 | 0.93 | +31.2% |
| Wtd Avg Shares (Basic) | 118,144 | 123,215 | -4.1% |
| Wtd Avg Shares (Diluted) | 122,875 | 126,644 | -3.0% |
| Comprehensive Income | 155,438 | 110,853 | +40.2% |
| Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax | 1,325 | -208 | +737.0% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 309,749 | 176,328 | +75.7% |
| Debt Securities Available For Sale Excluding Accrued Interest Current | 8,873 | 571,594 | -98.4% |
| Accounts Receivable And Contract With Customer Asset After Allowance For Credit Loss Current | 457,989 | 304,621 | +50.3% |
| Inventory | 155,467 | 164,868 | -5.7% |
| Prepaid Expenses & Other Current Assets | 70,958 | 44,617 | +59.0% |
| Total Current Assets | 1,003,036 | 1,262,028 | -20.5% |
| Accounts Receivable | 457,989 | 304,025 | +50.6% |
| Non-Current Assets | |||
| Prepaid Expense And Other Assets Noncurrent | 50,915 | 55,609 | -8.4% |
| Goodwill | 582,323 | — | — |
Show Business Acquisition breakouts |
|||
| Elektrofi, Inc | 165,502 | — | — |
| Restricted Cash And Cash Equivalents Noncurrent | 2,260 | — | — |
| Total Assets | 2,672,719 | 2,196,532 | +21.7% |
| Property, Plant & Equipment | 46,934 | 40,222 | +16.7% |
| Operating Lease Right-of-Use Assets | 35,296 | 32,594 | +8.3% |
| Intangible Assets | 951,955 | 335,368 | +183.9% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Auto-injector technology platform | 180,622 | 238,051 | -24.1% |
| Customer Relationships | 458,424 | — | — |
| Hypercon developed technology platform | 224,335 | — | — |
| Trade name | 4,877 | — | — |
| XYOSTED proprietary product | 83,697 | 97,317 | -14.0% |
| Other Assets | |||
| Property Plant And Equipment And Operating Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 82,230 | 72,816 | +12.9% |
| Intangible Assets Net Excluding Goodwill | 951,955 | — | — |
| Current Liabilities | |||
| Accounts Payable | 14,098 | 20,074 | -29.8% |
| Accrued Liabilities | 140,369 | 130,305 | +7.7% |
| Current Portion of Long-Term Debt | 208,743 | — | — |
| Total Current Liabilities | 363,210 | 150,379 | +141.5% |
| Non-Current Liabilities | |||
| Long-Term Debt | 1,935,896 | — | — |
| Other Non-Current Liabilities | 106,448 | 56,436 | +88.6% |
| Deferred Tax Liabilities | 47,529 | — | — |
| Total Liabilities | 2,453,083 | 1,714,262 | +43.1% |
| Long-Term Debt (Q) | — | — | — |
Show Debt Instrument breakouts |
|||
| 2027 Convertible Notes · Convertible Debt | 208,742 | — | — |
| 2031 Convertible Notes · Convertible Debt | 735,622 | — | — |
| 2032 Convertible Notes · Convertible Debt | 735,316 | — | — |
| Convertible Senior Notes due 2028 · Convertible Debt | 464,959 | — | — |
Show Long-Term Debt Type breakouts |
|||
| Convertible Debt | 2,144,639 | — | — |
| Stockholders' Equity | |||
| Common Stock | 118 | 123 | -4.1% |
| Additional Paid In Capital Common Stock | 27,386 | 7,596 | +260.5% |
| Accumulated Other Comprehensive Income | -12,703 | -3,413 | -272.2% |
| Retained Earnings | 204,835 | 477,964 | -57.1% |
| Total Stockholders' Equity | 219,636 | 482,270 | -54.5% |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -12,703 | -3,413 | -272.2% |
| Additional Paid In Capital | 27,386 | 7,596 | +260.5% |
| Common Stock | 118 | 123 | -4.1% |
| Retained Earnings | 204,835 | 477,964 | -57.1% |
| Total Liabilities & Equity | 2,672,719 | 2,196,532 | +21.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Stock-Based Compensation | 16,637 | 10,673 | +55.9% |
| Depreciation & Amortization | 4,221 | 2,687 | +57.1% |
| Amortization Of Debt Discount Premium | 2,245 | 1,846 | +21.6% |
Show Debt Instrument breakouts |
|||
| 2027 Convertible Notes · Convertible Debt | 226 | 862 | -73.8% |
| 2031 Convertible Notes · Convertible Debt | 730 | — | — |
| 2032 Convertible Notes · Convertible Debt | 532 | — | — |
| Convertible Senior Notes due 2028 · Convertible Debt | 521 | 787 | -33.8% |
Show Long-Term Debt Type breakouts |
|||
| Convertible Debt | 2,009 | 1,649 | +21.8% |
| Accretion Amortization Of Discounts And Premiums Investments | -30 | -1,709 | +98.2% |
| Deferred Rent Payments | 214 | 253 | -15.4% |
| Increase Decrease In Deferred Income Taxes | 3,428 | -2,858 | +219.9% |
| Change in Accounts Receivable | -19,547 | 3,834 | -609.8% |
| Change in Inventory | 27,379 | -586 | +4772.2% |
| Change in Prepaid & Other Assets | -9,108 | -4,995 | -82.3% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -24,922 | 9,219 | -370.3% |
| Net Cash from Operations | 180,078 | 154,221 | +16.8% |
| Investing Activities | |||
| Purchases of Investments | -8,846 | -139,639 | +93.7% |
| Proceeds From Sale Of Available For Sale Securities Debt | 9,000 | 50,167 | -82.1% |
| Proceeds From Previous Acquisition | 710 | — | — |
| Capital Expenditures | -3,741 | -950 | -293.8% |
| Net Cash from Investing | -2,877 | -90,422 | +96.8% |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 170 | 95 | +78.9% |
| Financing Activities | |||
| Tax Withholding for Share Compensation | -1,613 | -3,321 | +51.4% |
| Net Cash from Financing | -1,613 | -3,321 | +51.4% |
| Supplemental | |||
| Unpaid Capital Expenditures | 1,747 | 488 | +258.0% |
| Other Cash Flow | |||
| Net Change in Cash | 175,588 | 60,478 | +190.3% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 312,009 | 176,328 | +76.9% |
Values in thousands USD. Source: SEC EDGAR 10-Q filing.